Cargando…

Targeting the Orexin System for Prescription Opioid Use Disorder

Prescription opioids are potent analgesics that are used for clinical pain management. However, the nonmedical use of these medications has emerged as a major concern because of dramatic increases in abuse and overdose. Therefore, effective strategies to prevent prescription opioid use disorder are...

Descripción completa

Detalles Bibliográficos
Autores principales: Matzeu, Alessandra, Martin-Fardon, Rémi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225970/
https://www.ncbi.nlm.nih.gov/pubmed/32290110
http://dx.doi.org/10.3390/brainsci10040226
_version_ 1783534177520451584
author Matzeu, Alessandra
Martin-Fardon, Rémi
author_facet Matzeu, Alessandra
Martin-Fardon, Rémi
author_sort Matzeu, Alessandra
collection PubMed
description Prescription opioids are potent analgesics that are used for clinical pain management. However, the nonmedical use of these medications has emerged as a major concern because of dramatic increases in abuse and overdose. Therefore, effective strategies to prevent prescription opioid use disorder are urgently needed. The orexin system has been implicated in the regulation of motivation, arousal, and stress, making this system a promising target for the treatment of substance use disorder. This review discusses recent preclinical studies that suggest that orexin receptor blockade could be beneficial for the treatment of prescription opioid use disorder.
format Online
Article
Text
id pubmed-7225970
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-72259702020-05-18 Targeting the Orexin System for Prescription Opioid Use Disorder Matzeu, Alessandra Martin-Fardon, Rémi Brain Sci Review Prescription opioids are potent analgesics that are used for clinical pain management. However, the nonmedical use of these medications has emerged as a major concern because of dramatic increases in abuse and overdose. Therefore, effective strategies to prevent prescription opioid use disorder are urgently needed. The orexin system has been implicated in the regulation of motivation, arousal, and stress, making this system a promising target for the treatment of substance use disorder. This review discusses recent preclinical studies that suggest that orexin receptor blockade could be beneficial for the treatment of prescription opioid use disorder. MDPI 2020-04-10 /pmc/articles/PMC7225970/ /pubmed/32290110 http://dx.doi.org/10.3390/brainsci10040226 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Matzeu, Alessandra
Martin-Fardon, Rémi
Targeting the Orexin System for Prescription Opioid Use Disorder
title Targeting the Orexin System for Prescription Opioid Use Disorder
title_full Targeting the Orexin System for Prescription Opioid Use Disorder
title_fullStr Targeting the Orexin System for Prescription Opioid Use Disorder
title_full_unstemmed Targeting the Orexin System for Prescription Opioid Use Disorder
title_short Targeting the Orexin System for Prescription Opioid Use Disorder
title_sort targeting the orexin system for prescription opioid use disorder
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225970/
https://www.ncbi.nlm.nih.gov/pubmed/32290110
http://dx.doi.org/10.3390/brainsci10040226
work_keys_str_mv AT matzeualessandra targetingtheorexinsystemforprescriptionopioidusedisorder
AT martinfardonremi targetingtheorexinsystemforprescriptionopioidusedisorder